Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|25|11|1294-1310

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.25, Iss.11, 2018-04, pp. : 1294-1310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome – 11β-hydroxysteroid dehydrogenase type 1

By Stewart Paul M  

Clinical Medicine, Vol. 5, Iss. 2, 2005-03 ,pp. : 142-146

Royal College Of Physicians

Access to resources Recommend Favorite

Tissue-Specific Glucocorticoid Reactivating Enzyme, 11#946;-Hydroxysteoid Dehydrogenase Type 1 (11#946;-HSD1) - A Promising Drug Target for the Treatment of Metabolic Syndrome

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 255-262

Bentham Science Publishers

Access to resources Recommend Favorite

Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3

By Hines Ronald N  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 41-49

Informa Healthcare

Access to resources Recommend Favorite

Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment

By Garruti Gabriella   Depalo Raffaella   Vita Maria Grazia   Lorusso Filomenamila   Giampetruzzi Federica   Damato Aurelia Bellomo   Giorgino Francesco  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 552-563

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Tissue-specific HIV-1 infection: why it matters

By Karris Maile AY   Smith Davey M  

Future Virology, Vol. 6, Iss. 7, 2011-07 ,pp. : 869-882

Future Medicine

Access to resources Recommend Favorite